Facial Injectables Market - Forecast(2024 - 2030)

Report Code: HCR 55432 Report Format: PDF + Excel

Facial Injectables Market Overview 

Facial Injectables Market size is estimated to reach $22.2 billion by 2026, growing at a CAGR of 8.8% during the forecast period 2021-2026. Facial Injectables are the face skin fillers that are used in many applications, such as dark circles removal, thinning of the lips, enhancement of cheekbones, and other applications. These injectables are also used to reduce wrinkles and smoothen skin appearance caused by aging and acne. These injectable fillers are injected into the lines and tissues of the face to restore the facial fullness that decreases with age and also fewer the appearance of wrinkles. Rise in the adoption of injectable dermal fillers, such as calcium hydroxylapatite and polymer fillers, growing demand for hyaluronic acid injectable fillers for lip augmentation, and increase in the adoption of injectable fillers for facial line correction are the factors that are set to drive the growth of the Facial Injectables Market for the period 2021-2026.

Facial Injectables Market Report Coverage

The report: “Facial Injectables Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Facial Injectables Market.

By Product Type: Collagen Fillers, Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Hyaluronic Acid (HA), and Polymer Fillers.
By Application: Lip Augmentation, Facial Line Correction, Face Lift, Lipoatrophy Treatment, Acne Scar Treatment, and Others.
By End User: Hospitals, Beauty Clinics, Dermatology Clinics, and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa).

Key Takeaways

  • Geographically, North America Facial Injectables Market accounted for the highest revenue share in 2020 and it is poised to dominate over the period 2021-2026 owing to the growing demand for hyaluronic acid injectable fillers for lip augmentation.
  • The rise in the adoption of calcium hydroxylapatite injectable filler for facial line correction is driving the Facial Line Correction segment. However, the side effects of existing injectable dermal fillers is one of the major factors that is said to reduce the growth of the Facial Injectables Market.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Facial Injectables Market report.

 Facial Injectables Market: Market Share (%) By Application, 2020

For More Details on This Report - Request for Sample

Facial Injectables Market Segment Analysis-By Product Type

The Facial Injectables Market based on the Product Type can be further segmented into Collagen Fillers, Botulinum Toxin Type A, Calcium Hydroxylapatite (CaHA), Hyaluronic Acid (HA), and Polymer Fillers. The Botulinum Toxin Type A segment held the largest share in 2020 owing to the factors such as growing adoption of fillers and injectables among the middle-aged women to reverse the signs of aging and increase in the adoption of botulinum toxin type A to treat cervical dystonia. The rise in the demand for botulinum toxin type A to block acetylcholine release in the treatment of chronic sialorrhea is driving the growth of the Facial Injectables Market. The Hyaluronic Acid segment is estimated to be the fastest growing segment with a CAGR of 9.6% over the period 2021-2026. This growth is owing to its ability to store moisture in the skin and making the skin healthier. Hyaluronic Acid has a moisture-binding characteristic that helps in maintaining the vital moisture responsible for the plumpness of the facial skin.

Facial Injectables Market Segment Analysis-By Application

The Facial Injectables Market based on the Application can be further segmented into Lip Augmentation, Facial Line Correction, Face Lift, Lipoatrophy Treatment, Acne Scar Treatment, and Others. The Facial Line Correction segment held the largest share in 2020 attibuted to the factors such as increasing demand for softening the facial lines and folds among the young population and rise in the approvals of injectable treatments for facial wrinkles. The rise in the adoption of calcium hydroxylapatite injectable filler for facial line correction is driving the growth of the Facial Injectables Market. The Lip Augmentation segment is estimated to be the fastest growing segment with a CAGR of 9.5% over the period 2021-2026. This growth is owing to the factors such as the growing adoption of hyaluronic acid injectable fillers for lip augmentation and increase in the demand for reshaping of normal lips to improve the dimensional relation with the nose, teeth, and surrounding facial structures.

Facial Injectables Market Segment Analysis-By Geography

North America held the largest share with 32% of the overall market in 2020. The growth in this segment is owing to the factors such as the growing demand for botulinum toxin type A to block acetylcholine release in the treatment of chronic sialorrhea and rise in the number of the male population opting for aesthetic procedures. The rise in the demand for hyaluronic acid injectable fillers for lip augmentation is driving the growth of the Facial Injectables Market. Asia-Pacific is estimated to be the fastest growing segment over 2021-2026. The growth in this segment is owing to the factors such as the growing adoption of injectable dermal fillers, such as calcium hydroxylapatite and polymer fillers and increasing popularity of various facial injectable treatments for the reduction of skin folds.

Facial Injectables Market Drivers

Increase in the Adoption of Injectable Hyaluronic Acid Fillers

Injectable hyaluronic acid fillers are increasingly being adopted to reduce the appearance of fine lines and wrinkles and to create structure and volume to the face and lips. Injectable Hyaluronic Acid fillers also play an important part in the correction of changes associated with aging. Moreover, the widespread availability and continuous improvements in these fillers by the key players is further propelling the growth of the Facial Injectables Market.

Rise in the Number of Male Population Opting for Aesthetic Procedures

The male patient population across the world are opting for aesthetic procedures like facial line correction lip augmentation, acne treatment, face lift, and aesthetic procedures. Many young male patients in developed nations are also adopting injectable polymer fillers and calcium hydroxylapatite (CaHA) fillers for wrinkle removal, which is one of the major factors driving the growth of the Facial Injectables Market.

Facial Injectables Market Challenges              

Side Effects of Existing Facial Injectables

The popularity of various facial injectable treatments was increasing rapidly among the younger generation across the world for the reduction of skin folds, enhancement of lips, wrinkle removal, acne treatment, scars treatment, and other applications. However, the side effects of existing injectable dermal fillers, such as redness, bruising, and swelling is one of the major factors that is estimated to reduce the growth of the Facial Injectables Market.

Facial Injectables Market Competitive Landscape:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Facial Injectables Market. Key companies of this market are Allergan, Ipsen, Merz Pharma, Medytox Inc, BioScience GmbH, Sinclair Pharma, Anika Therapeutics, Inc, Galderma S.A., Suneva Medical, Inc, and Prollenium Medical Technologies Inc among others.

Acquisitions/Product Launches:

  • In February 2020, BioScience GmbH has launched Hyaprof Soft, which is a monodensified dermal filler suitable for superficial indications. Hyaprof Soft is designed to improve cohesivity and plasticity to allow homogeneous soft tissue rejuvenation and is also suitable for the correction of moderate, deeper lines, and philtrum treatment.
  • In May 2019, Allergan has launched its newest facial filler Juvéderm® Volux, which is a hyaluronic acid-based dermal filler that is designed to replace lost facial volume. Juvéderm® Volux is surprisingly dense and is also more adept at lifting the tissue.
  • In April 2019, Merz has launched the new Belotero® Revive Dermal Filler to improve skin hydration, reduce roughness and minimize the appearance of fine lines. This dermal filler product contains a unique combination of hyaluronic acid (HA) and glycerol.

Relevant Reports

Dermal Fillers And Botulinum Toxin Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2021 - 2026

Report Code: HCR 36920

Medical Aesthetics Market - Forecast (2021 - 2026)

Report Code: HCR 0133

For more Lifesciences and Healthcare Market reports, please click here

1. Facial Injectables Market - Overview
    1.1 Definitions and Scope
2. Facial Injectables Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Facial Injectables Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Facial Injectables Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Facial Injectables Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Facial Injectables Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Facial Injectables Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Facial Injectables Market – By Product Type(Market Size –$Million/$Billion)
    8.1 Collagen Fillers
    8.2 Botulinum Toxin Type A
    8.3 Calcium Hydroxylapatite (CaHA)
    8.4 Hyaluronic Acid (HA)
    8.5 Polymer Fillers
9. Facial Injectables Market – By Application(Market Size –$Million/$Billion)
    9.1 Lip Augmentation
    9.2 Facial Line Correction
    9.3 Face Lift
    9.4 Lipoatrophy Treatment
    9.5 Acne Scar Treatment
    9.6 Others
10. Facial Injectables Market – By End User(Market Size –$Million/$Billion)
    10.1 Hospitals
    10.2 Beauty Clinics
    10.3 Dermatology Clinics
    10.4 Others
11. Facial Injectables Market - By Geography(Market Size –$Million/$Billion)
    11.1 North America
        11.1.1 U.S.
        11.1.2 Mexico
        11.1.3 Canada
    11.2 Europe
        11.2.1 U.K.
        11.2.2 France
        11.2.3 Germany
        11.2.4 Italy
        11.2.5 Spain
        11.2.6 Russia
        11.2.7 Rest of Europe
    11.3 Asia Pacific
        11.3.1 China
        11.3.2 India
        11.3.3 Japan
        11.3.4 South Korea
        11.3.5 Australia & New Zealand
        11.3.6 Rest of Asia Pacific
    11.4 South America
        11.4.1 Brazil
        11.4.2 Argentina
        11.4.3 Rest of South America
    11.5 Rest of the World
        11.5.1 Middle East
        11.5.2 Africa
12. Facial Injectables Market - Entropy
13. Facial Injectables Market – Industry/Segment Competition Landscape Premium
    13.1.1 Global Market Share – Key Companies
        13.1.2 Market Share by Region – Key companies
        13.1.3 Market Share by Countries – Key Companies
        13.1.4 Best Practices for Companies
14. Facial Injectables Market – Key Company List by Country Premium Premium
15. Facial Injectables Market Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
1.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Global Industry Research
1.1.1 Hyaluronic Acid Market 2023-2030 ($M)
1.1.2 Collagen Fillers Market 2023-2030 ($M)
1.1.3 Synthetic Fillers Market 2023-2030 ($M)
1.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Global Industry Research
1.2.1 Botulinum Toxin A Market 2023-2030 ($M)
1.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
2.Global FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
2.1 Hospitals Market 2023-2030 ($M) - Global Industry Research
2.2 Dermatology Clinics Market 2023-2030 ($M) - Global Industry Research
2.3 Beauty Clinics Market 2023-2030 ($M) - Global Industry Research
2.4 Dermatology Research Institute Market 2023-2030 ($M) - Global Industry Research
3.Global FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 (Volume/Units)
3.1 Dermal Fillers/Injectable Implants Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Hyaluronic Acid Market 2023-2030 (Volume/Units)
3.1.2 Collagen Fillers Market 2023-2030 (Volume/Units)
3.1.3 Synthetic Fillers Market 2023-2030 (Volume/Units)
3.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Botulinum Toxin A Market 2023-2030 (Volume/Units)
3.2.2 Poly-L-Lactic Acid Market 2023-2030 (Volume/Units)
4.Global FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 (Volume/Units)
4.1 Hospitals Market 2023-2030 (Volume/Units) - Global Industry Research
4.2 Dermatology Clinics Market 2023-2030 (Volume/Units) - Global Industry Research
4.3 Beauty Clinics Market 2023-2030 (Volume/Units) - Global Industry Research
4.4 Dermatology Research Institute Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
5.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Hyaluronic Acid Market 2023-2030 ($M)
5.1.2 Collagen Fillers Market 2023-2030 ($M)
5.1.3 Synthetic Fillers Market 2023-2030 ($M)
5.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Botulinum Toxin A Market 2023-2030 ($M)
5.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
6.North America FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
6.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
6.2 Dermatology Clinics Market 2023-2030 ($M) - Regional Industry Research
6.3 Beauty Clinics Market 2023-2030 ($M) - Regional Industry Research
6.4 Dermatology Research Institute Market 2023-2030 ($M) - Regional Industry Research
7.South America FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
7.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Hyaluronic Acid Market 2023-2030 ($M)
7.1.2 Collagen Fillers Market 2023-2030 ($M)
7.1.3 Synthetic Fillers Market 2023-2030 ($M)
7.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Botulinum Toxin A Market 2023-2030 ($M)
7.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
8.South America FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
8.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
8.2 Dermatology Clinics Market 2023-2030 ($M) - Regional Industry Research
8.3 Beauty Clinics Market 2023-2030 ($M) - Regional Industry Research
8.4 Dermatology Research Institute Market 2023-2030 ($M) - Regional Industry Research
9.Europe FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
9.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Hyaluronic Acid Market 2023-2030 ($M)
9.1.2 Collagen Fillers Market 2023-2030 ($M)
9.1.3 Synthetic Fillers Market 2023-2030 ($M)
9.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Botulinum Toxin A Market 2023-2030 ($M)
9.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
10.Europe FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
10.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
10.2 Dermatology Clinics Market 2023-2030 ($M) - Regional Industry Research
10.3 Beauty Clinics Market 2023-2030 ($M) - Regional Industry Research
10.4 Dermatology Research Institute Market 2023-2030 ($M) - Regional Industry Research
11.APAC FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
11.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Hyaluronic Acid Market 2023-2030 ($M)
11.1.2 Collagen Fillers Market 2023-2030 ($M)
11.1.3 Synthetic Fillers Market 2023-2030 ($M)
11.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Botulinum Toxin A Market 2023-2030 ($M)
11.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
12.APAC FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
12.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
12.2 Dermatology Clinics Market 2023-2030 ($M) - Regional Industry Research
12.3 Beauty Clinics Market 2023-2030 ($M) - Regional Industry Research
12.4 Dermatology Research Institute Market 2023-2030 ($M) - Regional Industry Research
13.MENA FACIAL INJECTABLES MARKET, BY PRODUCT TYPE Market 2023-2030 ($M)
13.1 Dermal Fillers/Injectable Implants Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Hyaluronic Acid Market 2023-2030 ($M)
13.1.2 Collagen Fillers Market 2023-2030 ($M)
13.1.3 Synthetic Fillers Market 2023-2030 ($M)
13.2 Anti-aging/ Anti-wrinkle Injections Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Botulinum Toxin A Market 2023-2030 ($M)
13.2.2 Poly-L-Lactic Acid Market 2023-2030 ($M)
14.MENA FACIAL INJECTABLES MARKET, BY END USER Market 2023-2030 ($M)
14.1 Hospitals Market 2023-2030 ($M) - Regional Industry Research
14.2 Dermatology Clinics Market 2023-2030 ($M) - Regional Industry Research
14.3 Beauty Clinics Market 2023-2030 ($M) - Regional Industry Research
14.4 Dermatology Research Institute Market 2023-2030 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Facial Injectables Market Revenue, 2023-2030 ($M)
2.Canada Facial Injectables Market Revenue, 2023-2030 ($M)
3.Mexico Facial Injectables Market Revenue, 2023-2030 ($M)
4.Brazil Facial Injectables Market Revenue, 2023-2030 ($M)
5.Argentina Facial Injectables Market Revenue, 2023-2030 ($M)
6.Peru Facial Injectables Market Revenue, 2023-2030 ($M)
7.Colombia Facial Injectables Market Revenue, 2023-2030 ($M)
8.Chile Facial Injectables Market Revenue, 2023-2030 ($M)
9.Rest of South America Facial Injectables Market Revenue, 2023-2030 ($M)
10.UK Facial Injectables Market Revenue, 2023-2030 ($M)
11.Germany Facial Injectables Market Revenue, 2023-2030 ($M)
12.France Facial Injectables Market Revenue, 2023-2030 ($M)
13.Italy Facial Injectables Market Revenue, 2023-2030 ($M)
14.Spain Facial Injectables Market Revenue, 2023-2030 ($M)
15.Rest of Europe Facial Injectables Market Revenue, 2023-2030 ($M)
16.China Facial Injectables Market Revenue, 2023-2030 ($M)
17.India Facial Injectables Market Revenue, 2023-2030 ($M)
18.Japan Facial Injectables Market Revenue, 2023-2030 ($M)
19.South Korea Facial Injectables Market Revenue, 2023-2030 ($M)
20.South Africa Facial Injectables Market Revenue, 2023-2030 ($M)
21.North America Facial Injectables By Application
22.South America Facial Injectables By Application
23.Europe Facial Injectables By Application
24.APAC Facial Injectables By Application
25.MENA Facial Injectables By Application
26.Allergan, Plc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Anika Therapeutics, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Bloomage BioTechnology Corporation Limited, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.ColBar LifeScience Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Galderma Laboratories, L.P., Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Medytox, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Ipsen, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Merz, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Suneva Medical, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Sinclair Pharma Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)